Valeant Pharmaceuticals (VRX) agrees to buy Sanitas AB for ~€314M ($442M) in cash, plus the...

|About: Valeant Pharmaceuticals ... (VRX)|By:, SA News Editor

Valeant Pharmaceuticals (VRX) agrees to buy Sanitas AB for ~€314M ($442M) in cash, plus the assumption of €50M in debt. The deal will let Valeant "expand our European branded generics product portfolio with dermatology and hospital injectable compounds that have a strong track record of growth and profitability." (PR)